{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:23:13Z","timestamp":1747200193224,"version":"3.40.5"},"reference-count":47,"publisher":"Media Sphere Publishing House","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vestn. oftal'mol."],"published-print":{"date-parts":[[2022]]},"DOI":"10.17116\/oftalma2022138051126","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T18:30:54Z","timestamp":1666809054000},"page":"126","source":"Crossref","is-referenced-by-count":4,"title":["Use and outcomes of antioxidant therapy in ophthalmic practice"],"prefix":"10.17116","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8233-0385","authenticated-orcid":false,"given":"A.B.","family":"Movsisyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4437-9070","authenticated-orcid":false,"given":"Zh.G.","family":"Oganezova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6495-7173","authenticated-orcid":false,"given":"E.A.","family":"Egorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma2022138051126-1","unstructured":"Glaukoma. Natcionalnoe rukovodstvo [Glaucoma. National guideline]. Ed. Egorov E.A. M.: GEOTAR-Media; 2013. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-2","unstructured":"Kurysheva NI. Glaukomnaya opticheskaya neiropatiya [Glaucoma optic neuropathy]. M.: MEDpress-inform; 2006. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-3","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-02781-y"},{"key":"key-10.17116\/oftalma2022138051126-4","doi-asserted-by":"publisher","DOI":"10.1002\/cne.22783"},{"key":"key-10.17116\/oftalma2022138051126-5","unstructured":"Glaznye bolezni. Uchebnik [Eye diseases. Textbook]. Ed. Kopaeva V.G. M.: Medicina; 2018. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-6","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00315"},{"key":"key-10.17116\/oftalma2022138051126-7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2018.11.005"},{"key":"key-10.17116\/oftalma2022138051126-8","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0542"},{"key":"key-10.17116\/oftalma2022138051126-9","unstructured":"Gaponov DO, Prigodina EV, Grudina TV, Dorosevich AE. Modern view on the pathogenetic mechanisms of Parkinson\u2019s disease progression. RMJ. 2018;12(1):66-72. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-10","doi-asserted-by":"publisher","DOI":"10.32364\/2311-7729-2022-22-2-116-121"},{"key":"key-10.17116\/oftalma2022138051126-11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239267"},{"key":"key-10.17116\/oftalma2022138051126-12","unstructured":"Volchegorskiy IA, Tur EV, Solyannikova OV, Rykun VS, Berdnikova EV, Sumina MS, Dmitrienko VN. The influence of water soluble antioxidant agent (mexidol) on optic nerve and blood flow velocity in ocular and orbital arteries in patients with primary open-angle glaucoma. The Russian Annals of Ophthalmology = Vestnik oftal\u2019mologii. 2012;4:33-37. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-13","unstructured":"Nesterov AP. Glaukoma [Glaucoma]. M.: Meditsinskoe informatsionnoe agentstvo; 2008. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-14","unstructured":"European Glaucoma Society. Terminology and Guidelines for Glaucoma. 5th ed. Savona, Italy: PubliComm; 2020"},{"key":"key-10.17116\/oftalma2022138051126-15","unstructured":"Voronina TA. Mexidol: a spectrum of pharmacological effects. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(12):86-90. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-16","unstructured":"Shulkin AV. Mexidol influence on the development of the phenomen of neurons excitotoxicity in vitro. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(2):35-39. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-17","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201811810197"},{"key":"key-10.17116\/oftalma2022138051126-18","doi-asserted-by":"publisher","DOI":"10.17116\/otorino201984061108"},{"key":"key-10.17116\/oftalma2022138051126-19","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202212204175"},{"key":"key-10.17116\/oftalma2022138051126-20","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2020120051160"},{"key":"key-10.17116\/oftalma2022138051126-21","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2021121061139"},{"key":"key-10.17116\/oftalma2022138051126-22","doi-asserted-by":"publisher","DOI":"10.21685\/2072-3032-2021-1-1"},{"key":"key-10.17116\/oftalma2022138051126-23","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2018118091117"},{"key":"key-10.17116\/oftalma2022138051126-24","doi-asserted-by":"publisher","DOI":"10.15829\/1728-8800-2017-5-91-94"},{"key":"key-10.17116\/oftalma2022138051126-25","unstructured":"Spasennikov BA. Application of Mexidol in the therapy of cerebral stroke. NovaInfo.Ru. 2017;2(58):400-416. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-26","doi-asserted-by":"publisher","DOI":"10.17816\/rcf14163-70"},{"key":"key-10.17116\/oftalma2022138051126-27","unstructured":"Bashkatova VG, Rayevsky KS. Nitric oxide in mechanisms of brain damage induced by neurotoxic effect of glutamate. Biochemistry (Mosc) = Biokhimiya. 1998;63(7):1020-1028. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-28","unstructured":"Davydova ON, Boldyrev AA. Glutamate receptors in the cells of the nervous and immune systems. Annaly klinicheskoy i eksperimental\u2019noy nevrologii. 2007;1(4):28-34. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-29","unstructured":"Volchegorskiy IA, Rassohina LM, Miroshnichenko IYu. Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats. Eksperimental\u2019naya i klinicheskaya farmakologiya. 2011;74(5):17-25. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-30","unstructured":"Chesnokova NB, Beznos OV, Pavlenko TA, Serebryakova OE, Grigor\u2019ev AV, Zabozlaev AA, Pavlova MV. A Comparative Experimental Study of the Effect of 3-Oxypyridine Derivatives (Mexidol and Emoxipin) in Eyedrops on Local Metabolism and Healing of Alkali Burn Wounds of Various Localizations in Rabbit Eyes. Report 2: Afterburn Conjunctival Ischemia. Posleozhogovaja ishemija konjunktivy. Rossijskiy oftal\u2019mologicheskiy zhurnal. 2013;(2):94-99. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-31","unstructured":"Volchegorskiy IA, Rassohina LM, Miroshnichenko IYu. Comparative analysis of the effect of 3-hydroxypyridine and succinic acid derivatives on resistance to acute hypoxic hypoxia. Patogenez. 2008;6(3):50-51. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-32","unstructured":"Maychuk YuF, Pozdnyakov VI, Petrovich YuA, Maychuk NV. Experimental assessment of Mexidol eye drops influence on cornea healing, safety and antioxidant effect. Refrakcionnaya hirurgiya i oftal\u2019mologiya. 2009;9(4):36-40. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-33","unstructured":"Malyshev VE, Sal\u2019nikova OI. Experience of using the drug \u00abMexidol\u00bb in the complex outpatient treatment of patients with eye diseases of degenerative-dystrophic origin. Bjulleten\u2019 eksperimental\u2019noy biologii i meditsiny. 2006;(1):55-57. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-34","unstructured":"Bratko VI. Combined treatment of ophthalmopathology with the use of Mexidol. Byulleten\u2019 eksperimental\u2019noy biologii i meditsiny. 2012;(1):232-236. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-35","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202012003259"},{"key":"key-10.17116\/oftalma2022138051126-36","unstructured":"Maychuk YuF, Pozdnyakov VI. Mexidol in the complex therapy of ulcerative and dystrophic lesions of the cornea. Refrakcionnaya hirurgiya i oftal\u2019mologiya. 2010;10(4):43-46. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-37","unstructured":"Egorov EA, Obruch BV, Olejnik AI, Bordashevskaya LS, Kurabanova MR. Usage of Mexidol in patients with dystrophic diseases of posterior eye segment. Klinicheskaya oftal\u2019mologiya. 2009;10(4):145-148. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-38","unstructured":"Dorofeev DA. The use of antioxidant therapy in the complex treatment of primary open-angle glaucoma. In: III Nauchno-prakticheskaja olimpiada \u00abMeksidol: 20 let v klinicheskoj praktike\u00bb [III Scientific and Practical Olympiad \u00abMexidol: 20 years in clinical practice\u00bb]. Prilozhenie k zhurnalu \u00abTerapiya\u00bb. M.: Bionika Media; 2019. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-39","unstructured":"Egorov EA, Gvetadze AA, Davydova NG. Antioxidant agents in neuroprotection treatment of glaucoma. The Russian Annals of Ophthalmology = Vestnik oftal\u2019mologii. 2013;129(2):67-69. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-40","unstructured":"Bolatbekova AN, Kopbaeva DE, Arinova AI, Abrahmanova BS. Evaluation of the effectiveness of mexidol in the complex treatment of glaucoma neuropathy. Gigiena truda i medicinskaya ekologiya. 2015;2(47):67-77. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-41","unstructured":"Afonina EA, Levko MA, Chekurova LV, Kosacheva TI. Our experience of using mexidol in the complex treatment of patients with primary open-angle glaucoma. In: Rossiyskaya glaukomnaya shkola. Konferenciya \u00abGlaukoma: teoriya i praktika\u00bb [Russian glaucoma school. Conference \u00abGlaucoma: theory and practice\u00bb]. SPb.: Chelovek i ego zdorov\u2019e; 2013;8:33-37. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-42","unstructured":"Rossiyskaya glaukomnaya shkola. Konferenciya \u00abGlaukoma: teoriya i praktika\u00bb. Sbornik nauchnyh trudov [Russian glaucoma school. Conference \u00abGlaucoma: theory and practice\u00bb. Collection of scientific papers]. Eds Alekseev V.N., Sadkov V.I. SPb.: Chelovek i ego zdorov\u2019e; 2013. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-43","unstructured":"Loskutov IA, Andryuhina OM, Kovrizhkina AA. Use of Mexidol in the Therapy of Primary Open-angle Glaucoma. Effektivnaja farmakoterapiya. 2022; 18(1):60-64. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-44","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma2015131691-94"},{"key":"key-10.17116\/oftalma2022138051126-45","unstructured":"Egorov EA, Davydova NG, Romanenko IA, Novikova ND. Mexidol in complex treatment of glaucoma. Klinicheskaya oftal\u2019mologiya. 2011;12(3):107-110. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-46","unstructured":"Chesnokova NB, Beznos OV, Pavlenko TA, Serebryakova OE, Grigor\u2019ev AV, Zabozlaev AA, Pavlova MV. A comparative experimental study of the effect of 3-oxypyridine derivatives (Mexidol and Emoxipin) in eyedrops on local metabolism and healing of alkali burn wounds of various localizations of rabbit eyes. Report 1: Central cornea wounds. Rossijskiy oftal\u2019mologicheskiy zhurnal. 2013;(1):86-90. (In Russ.)"},{"key":"key-10.17116\/oftalma2022138051126-47","unstructured":"Egorov EA, Alekseev VN, Gazizova IR. Pervichnaya otkrytougol\u2019naya glaukoma: neyrodegeneraciya i neyroprotekciya [Primary open-angle glaucoma: neurodegeneration and neuroprotection]. M.: GEOTAR-Media; 2019. (In Russ.)"}],"container-title":["Vestnik oftal'mologii"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T18:32:10Z","timestamp":1666809130000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/vestnik-oftalmologii\/2022\/5\/10042465X2022051126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"alternative-id":["10.17116\/oftalma2022138051126"],"URL":"https:\/\/doi.org\/10.17116\/oftalma2022138051126","relation":{},"ISSN":["0042-465X"],"issn-type":[{"type":"print","value":"0042-465X"}],"subject":[],"published":{"date-parts":[[2022]]}}}